Medicines Development For Global Health

This study is testing an unapproved drug called dovramilast to see if it works better and is safer than current treatments for severe skin flare-ups caused by leprosy. Researchers will compare two doses of dovramilast against standard care in 45 adults over 12 weeks. The main goa…

This large study aims to see if a new combination of existing drugs (moxidectin, diethylcarbamazine, and albendazole) is safe and effective for treating three parasitic diseases—lymphatic filariasis, scabies, and strongyloidiasis—in communities in Fiji where these infections are …